Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain
<p>Abstract</p> <p>Background</p> <p>Mechanisms driving cancer-induced bone pain are poorly understood. A central factor implicated to be a key player in the process of tumorigenesis, osteoclastogenesis and nociception is p38 MAPK. We determined the role of p38 MAPK in...
Saved in:
Main Authors: | Vanderah Todd W (Author), Nelson Mark A (Author), Chandramouli Anupama (Author), Okun Alec (Author), Sukhtankar Devki (Author), Cress Anne E (Author), Porreca Frank (Author), King Tamara (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2011-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents
by: Mercado Ramon, et al.
Published: (2011) -
Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord
by: Cheng Hao, et al.
Published: (2011) -
STAT3 Inhibition in a Murine Model of Human Breast Cancer-Induced Bone Pain Delays Onset of Nociception
by: Manu Sharma, et al.
Published: (2019) -
p38 MAPK, microglial signaling, and neuropathic pain
by: Suter Marc R, et al.
Published: (2007) -
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats
by: Priyank Ashok Shenoy, et al.
Published: (2016)